KSE - Delayed Quote KRW
Hanall Biopharma Co., Ltd. (009420.KS)
26,600.00
-350.00
(-1.30%)
At close: 3:30:30 PM GMT+9
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 7 | 7 |
| Avg. Estimate | 0 | 0 | 139.26 | 329.81 |
| Low Estimate | 0 | 0 | 10.8 | 78.7 |
| High Estimate | 0 | 0 | 443 | 898 |
| Year Ago EPS | -- | -- | -36 | 139.26 |
Revenue Estimate
| Currency in KRW | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 5 | 7 |
| Avg. Estimate | 36.2B | 36.5B | 155B | 178.37B |
| Low Estimate | 36.2B | 36.5B | 150.1B | 163B |
| High Estimate | 36.2B | 36.5B | 164B | 227.2B |
| Year Ago Sales | 34.1B | 31.59B | 138.94B | 155B |
| Sales Growth (year/est) | 6.16% | 15.53% | 11.56% | 15.08% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 139.26 | 329.81 |
| 7 Days Ago | 0 | 0 | 156.8 | 609.39 |
| 30 Days Ago | 0 | 0 | 199.2 | 590 |
| 60 Days Ago | 0 | 0 | 114.33 | 458 |
| 90 Days Ago | 0 | 0 | 398 | 835.17 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 009420.KS | -- | -- | 486.83% | 136.84% |
| S&P 500 | 13.20% | 2.98% | 8.01% | 13.77% |